- Home
- IVT vs SRPT Comparison
IVT vs SRPT Comparison
Compare IVT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVT | SRPT |
|---|---|---|
| Founded | 2005 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IVT | SRPT |
|---|---|---|
| Price | $32.44 | $16.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 29 |
| Target Price | ★ $32.50 | $25.85 |
| AVG Volume (30 Days) | 364.1K | ★ 2.7M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 647.37 | N/A |
| EPS | 0.07 | ★ 2.88 |
| Revenue | $299,169,000.00 | ★ $2,198,237,000.00 |
| Revenue This Year | $8.42 | N/A |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | $454.14 | ★ $5.91 |
| Revenue Growth | 9.20 | ★ 15.58 |
| 52 Week Low | $26.52 | $10.42 |
| 52 Week High | $33.19 | $44.14 |
Technical Indicators
Market Signals| Indicator | IVT | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 57.85 | 29.88 |
| Support Level | $30.31 | $16.09 |
| Resistance Level | $32.91 | $19.32 |
| Average True Range (ATR) | 0.61 | 1.13 |
| MACD | -0.02 | -0.52 |
| Stochastic Oscillator | 89.62 | 0.72 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.